Expressions of MAGE-A 3, MAGE-A 6 and MAGE-A 10 genes in peripheral blood of patients with colorectal carcinoma and their clinical signi cance

HAN Jun-yi,YANG Yao,DING Han-zhi,GAO Wei,YAN Dong-yi,CHEN Qi-liang,YIN Hua,GE Hai-yan,LU Ai-guo

DOI: https://doi.org/10.3781/j.issn.1000-7431.2012.11.010

2012-01-01

Tumor

Abstract:Objective: To analyze the mRNA expression levels of MAGE (melanoma antigen encoding gene)-A3, MAGE -A6 and MAGE -A10 in peripheral blood of patients with CRC (colorectal carcinoma), and to study their clinical significance. Methods: Peripheral blood samples were collected from 35 CRC patients and 15 healthy donors. RFQ-PCR (real-time fluorescent quantitative PCR) was performed to detect the mRNA expression levels of MAGE-A3, MAGE-A6 and MAGE-A10 for all samples. The correlation of clinicopathological characteristics (gender, age, primary tumor lesion, histologic grading, depth of invasion, lymph node metastasis, Dukes’ staging) with the expressions of MAGE-A6 and MAGE-A10 mRNAs in peripheral blood of patients with CRC (colorectal cancer) was evaluated. Results: MAGE-A3 mRNA expression was not detected in all peripheral blood samples. The positive rate of MAGE-A6 mRNA in CRC group was significantly higher than that in healthy control group (P = 0.000 0), and its expression level in CRC male patients was significantly higher than that in female patients (P = 0.045 9). Furthermore, MAGE-A6 mRNA was more significantly expressed in CRC patients with lymph node metastasis compared with the patients without lymph node metastasis (P = 0.000 0). The positive rate of MAGE-A10 mRNA in CRC group was also significantly higher than that in healthy control group (P = 0.022 4), and theexpression level in CRC patients with lymph node metastasis was significantly higher than that in patients without lymph node metastasis (P = 0.000 0). Conclusion: The mRNA expression level of MAGE-A6 and MAGE-A10 in peripheral blood of CRC patients shows an important significance for CRC metastasis detection, and it may become a potential clinical marker for the diagnosis of micro-metastasis in lymph nodes, treatment selection and prognostic judgement of CRC.